Finland· FI-REL-REL63496
Waskyra
A other hematological agents product containing etuvetidigene autotemcel, registered in Finland by Fondazione Telethon Ets. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Etuvetidigene autotemcel is registered in 4 of 19 countries.
Countries holding a registration under ATC B06 (other hematological agents), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Etuvetidigene autotemcel · ATC B06
4 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Netherlands
The record
At a glance
Fimea (Finland)- Active substance
- Etuvetidigene autotemcel
- Manufacturer
- Fondazione Telethon Ets
- Country
- Finland (FI)
- ATC code
- B06
- ATC class
- OTHER HEMATOLOGICAL AGENTS
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etuvetidigene autotemcel in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesWASKYRAFondazione Telethon ETS
- BelgiumWaskyra 2 10*6 cells/ml - 10 10*6 cells/mlFondazione Telethon ETS
- CzechiaWASKYRAFondazione Telethon ETS, Řím
- NetherlandsWaskyra 2-10 x 10^6 cellen/ml dispersie voor infusieFondazione Telethon
- PolandWaskyraFondazione Telethon ETS
- SwedenWaskyra 2 - 10 miljoner celler/ml Infusionsvätska, dispersionFondazione Telethon ETS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Waskyra
- Liechtenstein · Waskyra
- Norway · Waskyra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c414b323-6138-4453-a470-dacfb03b6963 GET /v1/drugs/c414b323-6138-4453-a470-dacfb03b6963?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusioneste, dispersio",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "2-10 x 10^6 solua/ml",
"atc_label": "MUUT HEMATOLOGISET VALMISTEET",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/25/1996/001",
"fimea_rel_id": "REL63496",
"authorised_at": "2026-01-09"
}See everything about etuvetidigene autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.